Clinical Trial Update: First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating first-line pembrolizumab with plinabulin plus etoposide and platinum for extensive-stage small cell lung cancer is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Plinabulin (plinabulin)

Snippet

Sponsor: Xiaorong Dong | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: RECRUITING